NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy-Reference-Cited by-同舟云学术

NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy

Published:2021-12-15 Issue:2 Volume:10 Page:162-181
ISSN:2326-6066
Container-title:Cancer Immunology Research
language:en
Short-container-title:Cancer Immunol Res

Author:

Wen Ti^ORCID,Barham Whitney,Li Ying,Zhang Henan^ORCID,Gicobi Joanina K.,Hirdler Jacob B.,Liu Xin,Ham Hyoungjun,Peterson Martinez Kodi E.,Lucien Fabrice,Lavoie Roxane R.,Li Hu,Correia Cristina^ORCID,Monie Dileep D.^ORCID,An Zesheng,Harrington Susan M.,Wu Xiaosheng,Guo Ruifeng,Dronca Roxana S.,Mansfield Aaron S.^ORCID,Yan Yiyi^ORCID,Markovic Svetomir N.^ORCID,Park Sean S.^ORCID,Sun Jie,Qin Hong,Liu Minetta C.^ORCID,Vasmatzis George,Billadeau Daniel D.^ORCID,Dong Haidong^ORCID

Funder

NIH

National Institute of General Medical Sciences

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Immunology

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of key immune-related genes and potential therapeutic targets in immune checkpoint inhibitor–associated myocarditis;Postgraduate Medical Journal;2024-09-10

2. A Unified Atlas of T cell Glycophysiology;2024-08-25

3. Identification of hub modules and therapeutic targets associated with CD8+T-cells in HF and their pan-cancer analysis;Scientific Reports;2024-08-13

4. The role of CD4+ T cells in visceral leishmaniasis; new and emerging roles for NKG7 and TGFβ;Frontiers in Cellular and Infection Microbiology;2024-05-31

5. Batf3+ DCs and the 4-1BB/4-1BBL axis are required at the effector phase in the tumor microenvironment for PD-1/PD-L1 blockade efficacy;Cell Reports;2024-05